Results
|
65721.
|
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy. [electronic resource] by
- Bazinet, Michel
- Pântea, Victor
- Placinta, Gheorghe
- Moscalu, Iurie
- Cebotarescu, Valentin
- Cojuhari, Lilia
- Jimbei, Pavlina
- Iarovoi, Liviu
- Smesnoi, Valentina
- Musteata, Tatiana
- Jucov, Alina
- Dittmer, Ulf
- Krawczyk, Adalbert
- Vaillant, Andrew
Producer: 20210217
In:
Gastroenterology vol. 158
Availability: No items available.
|
|
65722.
|
|
|
65723.
|
|
|
65724.
|
|
|
65725.
|
|
|
65726.
|
|
|
65727.
|
|
|
65728.
|
|
|
65729.
|
|
|
65730.
|
|
|
65731.
|
|
|
65732.
|
|
|
65733.
|
|
|
65734.
|
|
|
65735.
|
|
|
65736.
|
|
|
65737.
|
|
|
65738.
|
|
|
65739.
|
|
|
65740.
|
|